Skip to main content

Hunt Ronald

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Hunt Ronald as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

HARP Harpoon Therapeutics, Inc.

Director, 10% Owner5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 27, 2023 (view filing)Oct 252 daysHunt RonaldDirector, 10% OwnerPPurchase+1.54M––New position395.8K after2 lots
Oct 27, 2023 (view filing)Oct 252 daysHunt RonaldDirector, 10% OwnerPPurchase+771.8K–––85.8K afterDerivative2 lots
Mar 27, 2023 (view filing)Mar 234 daysHunt RonaldDirector, 10% OwnerPPurchase8.000% Series A Redeemable Preferred Stock+10.0K$1,000.00+$10.0MNew position10.0K after
Mar 27, 2023 (view filing)Mar 234 daysHunt RonaldDirector, 10% OwnerPPurchase+2.99M–––2.99M afterDerivative
Aug 12, 2021 (view filing)Jan 11213 daysLateHunt RonaldDirector, 10% OwnerPPurchase+235.3K$17.00+$4.00M+34.7%913.9K after

RLYB Rallybio Corp

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 4, 2021 (view filing)Aug 22 daysHunt RonaldDirectorPPurchase+307.7K$13.00+$4.00M+15.4%2.30M after2 lots